https://www.selleckchem.com/pr....oducts/pha-848125.ht
Data from 37 patients (19 control/18 NMES) who completed the trial were analyzed. The trial was registered at ClinicalTrials.gov (NCT0389246. Physical function measures improved from discharge to 4 wk post-surgery across our entire cohort (P .001). Patients randomized to NMES, however, showed greater improvements in 6-min walk test distance and power output compared with controls (P .01). Our results provide evidence supporting the utility of NMES to accelerate recovery of physical function after coronary artery bypass gr
Like
Comment
Share
